Data as of Dec 11
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +194.12% increase from the last price of 1.19.
The current consensus among 2 polled investment analysts is to Buy stock in Cleveland Biolabs Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.